sameAs
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesDefining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus reportCardiovascular complications of type 1 diabetes: update on the renal link.IDDM incidence in a multiracial population. The Hawaii IDDM Registry, 1980-1990.Modifications of coronary risk factors.Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in the diabetes control and complications trial.Archaeological data provide alternative hypotheses on Pacific herring (Clupea pallasii) distribution, abundance, and variability.Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.A multinational assessment of complications in type 1 diabetes: the DiaMond substudy of complications (DiaComp) level 1.Retinal vessel diameter and the incidence of coronary artery disease in type 1 diabetes.Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction ruleAre hemoglobin levels elevated in type 1 diabetes?Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetesThe distribution and associations of blood pressure in an adolescent population.The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes.Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.A randomized trial of therapies for type 2 diabetes and coronary artery diseaseIs glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescenceSkin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes.Development of a coronary heart disease risk prediction model for type 1 diabetes: the Pittsburgh CHD in Type 1 Diabetes Risk Model.Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes.Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes.Regional adiposity and risk for coronary artery disease in type 1 diabetes: does having greater amounts of gluteal-femoral adiposity lower the risk?Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study.Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose toleranceAll-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry.Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetesVariants of the adenosine A(2A) receptor gene are protective against proliferative diabetic retinopathy in patients with type 1 diabetes.Pulse wave analysis and prevalent cardiovascular disease in type 1 diabetesQuantitation of 3-deoxyglucosone levels in human plasma.Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention ProgramUrinary microRNA profiling in the nephropathy of type 1 diabetes.Characterizing sudden death and dead-in-bed syndrome in Type 1 diabetes: analysis from two childhood-onset Type 1 diabetes registries.Augmentation pressure and subendocardial viability ratio are associated with microalbuminuria and with poor renal function in type 1 diabetes.Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort.In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.
P50
Q22250887-85F833C0-9F3E-4674-B14F-CAC0CD5B050BQ27687598-4EF51999-13E7-4CF9-B00A-8A4A374B6038Q30239971-EF0CA6D0-4D93-4B0A-B069-B423CE08378DQ30427400-66D07D10-20A0-493A-8B5C-82CC61754F81Q30439801-AC935075-3116-4430-AE1B-18EC09B74C16Q30490712-38CAD5D9-2065-4DAE-A051-761E198C84F0Q30573809-FBA8A511-6501-4013-9713-9102121E7094Q30789138-F170D39D-F0D2-4601-9B55-7D52D00EC3B5Q33261207-D7414C38-DE38-45F8-8088-7EE85E6B3DAEQ33400921-D838D8FB-9B25-454B-8704-7C5D8FCF9E7AQ33555198-3F0795EA-AA28-46F0-BB05-34BA7D789E01Q33602249-2F2ED5ED-43BB-4C5D-BB9E-6C83AA605A66Q33683797-0C384225-CDD6-4F04-BEBF-C086CD2EE40FQ33684460-A267B0BE-37AA-47C5-8CC1-8B6C6B582B45Q33771752-03F7131C-CC3D-4A12-B055-75B7BA50515BQ33805731-195ABA73-42F1-4651-820B-DFB118984BF5Q33827504-B703EFC2-DD92-41A4-8A46-9D799A40E91DQ33833060-6A89E558-3BB2-4076-B23C-FA56FF0A7A08Q33835519-EF05916E-9D6B-40FD-AD45-36116A2B8874Q33839324-AE92D928-DC7A-4016-86D8-80FC5B725518Q33905029-94B7B6EE-5B1C-41DD-8130-C67E8DAD212EQ33937293-A8B1254D-E9E0-4C6E-9DB8-68A0EB85561AQ33960260-CF05C6F4-85CF-4D87-B3E6-990C510A4C61Q34051581-EF733E74-067A-495A-811A-9FF3F6CF1428Q34057903-96AEAF42-8753-49A2-97D0-748CF8D02FC3Q34073458-A95CE0BE-E8BB-4D84-992E-B546DF86D2CAQ34195798-41D3716B-11B6-483C-BC5F-9FF578B5406CQ34219439-82DA8A91-7C53-4E3C-BD38-DF417251C253Q34225645-F8BBBA29-7456-4681-BEFD-413C0FB09D6AQ34351765-93272A05-0F9E-43CE-8624-0E944D29AF58Q34355350-2FA9F373-6759-49B3-B495-8D647841A94AQ34382202-25631E70-29F2-4D20-9112-46353D624D93Q34384850-0D0849B7-8764-46E5-82F5-862369A2A3F4Q34429093-FE72DD58-C397-4D61-B1C9-324099C2B628Q34489251-91E570E5-9F0F-4642-A254-1E2115C08114Q34566051-9CC862E4-B327-4856-9866-EE9BC4A2AA2EQ34609673-78006957-DF47-434F-B640-91DEC0FB5C79Q34618783-09FCCE0D-ACA0-470A-96E1-6395A0CBA9DFQ34641067-72DB93F0-6B7F-4AC3-805A-CD611111D1DDQ34669819-AD0DE689-FCC4-4903-8966-83C2ADCEFEF1
P50
description
Amerikaans onderzoeker
@nl
hulumtues
@sq
researcher
@en
հետազոտող
@hy
name
Trevor J. Orchard
@ast
Trevor J. Orchard
@en
Trevor J. Orchard
@es
Trevor J. Orchard
@nl
type
label
Trevor J. Orchard
@ast
Trevor J. Orchard
@en
Trevor J. Orchard
@es
Trevor J. Orchard
@nl
altLabel
Orchard T J
@en
Orchard T
@en
Orchard T. J.
@en
Orchard TJ
@en
Orchard
@en
T J Orchard
@en
T Orchard
@en
T. J. Orchard
@en
T. Orchard
@en
Trevor J Orchard
@ast
prefLabel
Trevor J. Orchard
@ast
Trevor J. Orchard
@en
Trevor J. Orchard
@es
Trevor J. Orchard
@nl
P1153
56265414900
57193059637
P166
P21
P31
P496
0000-0001-9552-3215